Kerry Wentworth - Jun 21, 2021 Form 4 Insider Report for Flexion Therapeutics Inc (FLXN)

Role
Chief Regulatory Officer
Signature
/s/ Mark S. Levine, Attorney-in-Fact
Stock symbol
FLXN
Transactions as of
Jun 21, 2021
Transactions value $
$4,193
Form type
4
Date filed
6/28/2021, 06:09 PM
Previous filing
May 25, 2022
Next filing
Jul 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLXN Common Stock Award $4.19K +539 +0.37% $7.78 144K Jun 21, 2021 Direct F1
holding FLXN Common Stock 6K Jun 21, 2021 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 539 shares by the Reporting Person on June 21, 2021, pursuant to the Issuer's Employee Stock Purchase Plan.